Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,281 | 1,940 | 1,970 | 1,850 | 1,960 |
| Receivables | 2,890 | 1,740 | 900 | 990 | 770 |
| Other current assets | 7 | 770 | 310 | 450 | 580 |
| TOTAL | $4,965 | $4,450 | $3,180 | $3,290 | $3,310 |
| Non-Current Assets | |||||
| PPE Net | 40 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 11 | 12 | 14 | 15 | 16 |
| TOTAL | $51 | $12 | $14 | $15 | $16 |
| Total Assets | $5,016 | $4,490 | $3,230 | $3,330 | $3,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,681 | 780 | 100 | 40 | 70 |
| Accrued Expenses | N/A | 310 | 310 | 860 | 310 |
| Other current liabilities | 107 | 1,410 | 890 | 550 | 1,100 |
| TOTAL | $2,975 | $2,500 | $1,300 | $1,460 | $1,490 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 940 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,975 | $2,500 | $1,300 | $1,460 | $1,490 |
| Shareholders' Equity | |||||
| Common Shares | 128 | 120 | 120 | 120 | 120 |
| Retained earnings | -11,732 | -11,780 | -11,840 | -11,890 | -11,880 |
| Other shareholders' equity | 70 | 70 | 70 | 70 | 80 |
| TOTAL | $2,040 | $1,980 | $1,920 | $1,870 | $1,880 |
| Total Liabilities And Equity | $5,016 | $4,480 | $3,220 | $3,330 | $3,370 |